These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. Fanning S; Haque A; Imberdis T; Baru V; Barrasa MI; Nuber S; Termine D; Ramalingam N; Ho GPH; Noble T; Sandoe J; Lou Y; Landgraf D; Freyzon Y; Newby G; Soldner F; Terry-Kantor E; Kim TE; Hofbauer HF; Becuwe M; Jaenisch R; Pincus D; Clish CB; Walther TC; Farese RV; Srinivasan S; Welte MA; Kohlwein SD; Dettmer U; Lindquist S; Selkoe D Mol Cell; 2019 Mar; 73(5):1001-1014.e8. PubMed ID: 30527540 [TBL] [Abstract][Full Text] [Related]
11. Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson's Disease Brains Are Differentially Generated in Mammalian Cell Models. Xin W; Emadi S; Williams S; Liu Q; Schulz P; He P; Alam NB; Wu J; Sierks MR Biomolecules; 2015 Jul; 5(3):1634-51. PubMed ID: 26287258 [TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract. Shaltiel-Karyo R; Davidi D; Frenkel-Pinter M; Ovadia M; Segal D; Gazit E Biochim Biophys Acta; 2012 Oct; 1820(10):1628-35. PubMed ID: 22575665 [TBL] [Abstract][Full Text] [Related]
13. Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies. Shaltiel-Karyo R; Frenkel-Pinter M; Egoz-Matia N; Frydman-Marom A; Shalev DE; Segal D; Gazit E PLoS One; 2010 Nov; 5(11):e13863. PubMed ID: 21085664 [TBL] [Abstract][Full Text] [Related]
14. α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner. Yin G; Lopes da Fonseca T; Eisbach SE; Anduaga AM; Breda C; Orcellet ML; Szegő ÉM; Guerreiro P; Lázaro DF; Braus GH; Fernandez CO; Griesinger C; Becker S; Goody RS; Itzen A; Giorgini F; Outeiro TF; Zweckstetter M Neurobiol Dis; 2014 Oct; 70():149-61. PubMed ID: 24983211 [TBL] [Abstract][Full Text] [Related]
15. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease. Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957 [TBL] [Abstract][Full Text] [Related]
16. Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease. Hideshima M; Kimura Y; Aguirre C; Kakuda K; Takeuchi T; Choong CJ; Doi J; Nabekura K; Yamaguchi K; Nakajima K; Baba K; Nagano S; Goto Y; Nagai Y; Mochizuki H; Ikenaka K Sci Rep; 2022 Jan; 12(1):351. PubMed ID: 35013421 [TBL] [Abstract][Full Text] [Related]
18. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation. Scheibe C; Karreman C; Schildknecht S; Leist M; Hauser K Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439733 [TBL] [Abstract][Full Text] [Related]
19. Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide. Mohammadi S; Nikkhah M; Hosseinkhani S Protein Pept Lett; 2017; 24(8):757-764. PubMed ID: 28820063 [TBL] [Abstract][Full Text] [Related]
20. Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease. Deas E; Cremades N; Angelova PR; Ludtmann MH; Yao Z; Chen S; Horrocks MH; Banushi B; Little D; Devine MJ; Gissen P; Klenerman D; Dobson CM; Wood NW; Gandhi S; Abramov AY Antioxid Redox Signal; 2016 Mar; 24(7):376-91. PubMed ID: 26564470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]